리서치사:Market Glass, Inc. (Formerly Global Industry Analysts, Inc.)
발행일:2024년 10월
페이지 정보:영문 93 Pages
라이선스 & 가격 (부가세 별도)
한글목차
척추성형술 세계 시장 규모는 2030년까지 4억 2,670만 달러에 달할 것으로 전망
2023년 2억 8,750만 달러로 추정되는 척추성형술 세계 시장은 2030년 4억 2,670만 달러에 달할 것으로 예상되며, 분석 기간인 2023-2030년 동안 연평균 5.8% 성장할 것으로 예상됩니다.
미국 시장 7,630만 달러로 추정, 중국은 CAGR 8.5%로 성장 전망
미국의 척추성형술 시장은 2023년 7,630만 달러로 추정됩니다. 세계 2위의 경제 대국인 중국은 2023-2030년 분석 기간 동안 8.5%의 CAGR로 성장하여 2030년에는 9,530만 달러의 시장 규모에 도달할 것으로 예상됩니다. 다른 주목할 만한 지역 시장으로는 일본과 캐나다가 있으며, 분석 기간 동안 각각 3.3%와 5.5%의 CAGR을 기록할 것으로 예측됩니다. 유럽에서는 독일이 연평균 3.4%의 성장률을 보일 것으로 예상됩니다.
세계 척추성형술 시장 동향 및 촉진요인 정리
척추성형술이란 무엇인가?
척추성형술은 주로 골다공증, 전이성 암, 외상으로 인한 고통스러운 척추압박골절(VCF)을 치료하기 위해 개발된 최첨단 최소침습 수술법입니다. 이 수술은 특수 아크릴 골 시멘트(가장 일반적인 것은 폴리메틸메타크릴레이트(PMMA)를 골절된 척추뼈에 직접 주입하여 척추를 안정시키고 통증을 빠르게 완화시킵니다. 척추성형술 동안 외과 의사는 시멘트를 정확하게 주입하기 위해 연속적인 실시간 투시 또는 CT 영상 안내하에 피부를 통해 골절된 뼈에 미세한 바늘을 조심스럽게 삽입합니다. 시멘트는 반 액체 상태로 주입되어 척추 내에서 빠르게 굳어 구조적 무결성을 효과적으로 복원하고 통증의 원인이 되는 미세한 움직임을 억제합니다. 척추성형술이 특히 매력적인 이유는 통증을 즉각적으로 완화하고 지속시킬 수 있기 때문에 수술 후 즉시 정상적인 활동을 재개할 수 있다는 점입니다. 척추성형술은 일반적으로 휴식, 통증 관리, 보조기 착용과 같은 보존적 치료에 반응하지 않는 환자에게 권장되며, 척추 골절 환자의 삶의 질을 향상시키는 중요한 선택이 되고 있습니다. 또한, 이 수술은 안전성 프로파일이 확립되어 있고, 최근 영상 진단 기술, 시멘트 구성 및 시술 방법의 발전으로 관련 위험이 크게 감소하여 정형외과 및 신경외과 분야에서 널리 인정받는 치료 옵션으로 자리 잡았습니다.
척추성형술의 주요 장점과 과제는 무엇인가?
척추성형술의 장점은 여러 측면에서 척추 압박 골절 환자에게 큰 임상적 이점을 가져다 주지만, 문제가 없는 것은 아닙니다. 주요 장점 중 하나는 통증이 신속하고 크게 감소한다는 점인데, 대부분의 경우 수술 후 몇 시간 이내에 통증이 감소하기 때문에 환자는 기존의 개복 수술 치료보다 훨씬 더 빨리 이동성을 회복하고 일상 생활로 돌아갈 수 있습니다. 이러한 빠른 회복은 특히 신체적 능력이 제한되어 있거나 여러 합병증으로 인해 치료가 복잡한 고령의 환자들에게 매우 중요합니다. 또한, 골절된 척추를 안정화시킴으로써 척척추성형술은 척추의 추가적 붕괴와 변형을 방지하고, 일반적으로 "혹살"로 알려진 후만증의 진행 위험을 감소시킵니다. 이러한 장점에도 불구하고 척추성형술은 의학계에서 큰 논란을 불러일으키고 있습니다. 그 주요 원인은 주입된 물질이 척추에서 인접한 구조물로 누출되어 신경근 압박, 색전증, 척수 손상을 유발할 수 있는 합병증에 대한 우려 때문입니다. 이러한 위험을 줄이기 위해 점도가 높은 시멘트를 사용하거나 시술 중 제어가 용이하도록 주입 기술을 개선하는 등 시멘트 제제의 개선이 진행되어 왔습니다. 또 다른 중요한 과제는 골절의 근본적인 원인에 따라 효과가 다르기 때문에 적절한 척추성형술의 과제를 선택하는 것입니다. 척추성형술은 골다공증성 골절의 치료에서 우수한 결과를 보이지만, 악성 병변이나 충격이 심한 외상으로 인한 골절에 대한 유효성은 아직 연구 중으로, 환자의 정확한 평가와 개별화된 치료 계획의 필요성이 강조되고 있습니다.
척추성형술과 다른 치료법과의 비교는?
척추성형술은 독특한 장점으로 인해 특정 유형의 척추 압박 골절에 대한 선호되는 치료법으로 두드러지지만, 종종 카이포플라스틱이나 척추 고정술과 같은 다른 치료법과 비교되지만, 각각 장점과 한계가 있습니다. 관련 수술인 카이포플라스틱은 시멘트를 주입하기 전에 풍선 탬핑을 사용하여 척추에 공동을 만들어 잃어버린 척추의 높이를 어느 정도 회복하고 척추의 변형을 교정하는 데 도움이 됩니다. 골단 성형술은 척추의 만곡을 억제하고 자세 이상을 예방하는 데 더 효과적이지만 일반적으로 척추성형술보다 비용과 시간이 더 많이 듭니다. 반면 척추성형술은 시멘트를 직접 주입하기 때문에 더 간단하고 빠르며 저렴합니다. 척추 고정술은 더 침습적인 수술 방법이며, 일반적으로 여러 개의 척추뼈가 있거나 척추가 심각하게 불안정한 경우에만 시행됩니다. 이 수술은 두 개 이상의 척추뼈를 영구적으로 결합하기 위해 뼈 이식과 금속 금속 장치를 사용하기 때문에 복잡성, 회복 시간 및 합병증 가능성이 높습니다. 척추성형술은 국소 마취로 시행되는 최소침습적 수술로, 대부분 외래환자로 시행되기 때문에 침습적인 수술에 필요한 장시간의 마취와 입원을 견딜 수 없는 노약자나 의료적으로 취약한 환자에게 이상적인 선택이 될 수 있습니다. 또한, 척추성형술의 통증 완화 및 골절 안정화 성공률은 침습적 수술과 비슷하거나 그 이상이기 때문에 특히 빠른 통증 완화와 정상 기능 회복이 주요 치료 목표인 경우 매우 유리한 선택이 될 수 있습니다. 그러나 이러한 옵션의 선택은 척추의 붕괴 정도, 전반적인 뼈의 건강 상태, 각 치료법의 위험과 이점을 충분히 논의한 후 환자 개인의 선호도 등 다양한 요인에 따라 달라질 수 있습니다.
척추성형술의 성장을 형성하는 시장 역학은 무엇인가?
척추성형술 시장의 성장은 골다공증 및 관련 척추 골절의 유병률 증가, 시술 기술의 발전, 덜 침습적인 치료 옵션에 대한 환자 선호도 변화 등 여러 가지 요인에 기인합니다. 골다공증은 고령자, 특히 폐경기 이후 여성에게 특히 흔하며, 이는 척추 압박 골절 치료를 필요로 하는 환자 수가 급증하는 것으로 이어지기 때문에 전 세계 고령화는 척추성형술에 대한 수요를 견인하는 중요한 요인입니다. 또한, 생체 활성 시멘트, 방사선 불투과성 시멘트와 같은 혁신적인 시멘트 제제의 도입으로 시술의 안전성과 치료 결과가 개선되면서 척추성형술은 환자와 의료진 모두에게 더욱 매력적인 선택이 되고 있습니다. 또한, 고화질 투시 및 실시간 3D 영상 등 영상 진단 기술의 발전으로 시술의 정확도가 향상되어 합병증과 시멘트 누출의 위험이 감소하고 있습니다. 외래 및 외래 수술에 대한 선호도가 높아진 것도 시장 확대에 기여하고 있습니다. 척추성형술은 장기 입원 없이도 시행할 수 있는 경우가 많아 전체 의료 비용을 절감하고 환자 만족도를 높일 수 있습니다. 소비자 행동 동향은 빠른 회복과 일상 생활에 지장을 주지 않는 치료에 대한 수요가 증가하면서 척추성형술의 채택을 더욱 촉진하고 있습니다. 척추 골절에 대한 조기 개입의 이점에 대한 의료 전문가와 환자의 인식이 높아짐에 따라 보다 적극적인 치료 전략으로 이어져 잠재적 환자층이 확대되고 있습니다. 또한, 새로운 시장 기업의 진입과 주요 이해관계자 간의 전략적 파트너십은 경쟁을 활성화하고 혁신을 촉진하여 척추성형술의 접근성을 높이고 비용을 낮출 것으로 예상됩니다. 그 결과, 척추성형술 시장은 인구 동향, 기술 혁신, 환자 및 의료 서비스 제공자의 선호도 변화에 힘입어 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상됩니다.
조사 대상 기업 예시(총 42건)
Alphatec Spine, Inc.
DePuy Synthes(Johnson & Johnson)
Globus Medical, Inc.
IZI Medial Products
Medtronic
Merit Medical Systems, Inc.
Rontis
SPINUS(BMK Global Medical Company)
Stryker Corporation
Zavation
목차
제1장 조사 방법
제2장 주요 요약
시장 개요
주요 기업
시장 동향과 성장 촉진요인
세계 시장 전망
제3장 시장 분석
미국
캐나다
일본
중국
유럽
프랑스
독일
이탈리아
영국
스페인
러시아
기타 유럽
아시아태평양
호주
인도
한국
기타 아시아태평양
라틴아메리카
아르헨티나
브라질
멕시코
기타 라틴아메리카
중동
이란
이스라엘
사우디아라비아
아랍에미리트
기타 중동
아프리카
제4장 경쟁
ksm
영문 목차
영문목차
Global Vertebroplasty Market to Reach US$426.7 Million by 2030
The global market for Vertebroplasty estimated at US$287.5 Million in the year 2023, is expected to reach US$426.7 Million by 2030, growing at a CAGR of 5.8% over the analysis period 2023-2030.
The U.S. Market is Estimated at US$76.3 Million While China is Forecast to Grow at 8.5% CAGR
The Vertebroplasty market in the U.S. is estimated at US$76.3 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$95.3 Million by the year 2030 trailing a CAGR of 8.5% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.3% and 5.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.4% CAGR.
Global Vertebroplasty Market - Key Trends and Drivers Summarized
What Is Vertebroplasty and How Does It Work?
Vertebroplasty is a cutting-edge, minimally invasive surgical procedure developed to treat painful vertebral compression fractures (VCFs) caused primarily by osteoporosis, metastatic cancers, or trauma. This procedure entails injecting a specialized acrylic bone cement, most commonly polymethylmethacrylate (PMMA), directly into the fractured vertebra to stabilize it and provide rapid pain relief. During vertebroplasty, the surgeon carefully inserts a thin needle through the skin into the fractured bone under continuous real-time fluoroscopic or CT imaging guidance to ensure precise placement of the cement. The cement is injected in a semi-liquid state and quickly hardens inside the vertebra, effectively restoring its structural integrity and reducing micromovements that are the source of pain. What makes vertebroplasty especially appealing is its ability to provide immediate and lasting pain relief, allowing patients to resume normal activities shortly after the procedure. It is typically recommended for patients who have not responded to conservative management, such as bed rest, pain medication, and bracing, making it a critical option for improving the quality of life in individuals with debilitating spinal fractures. Additionally, vertebroplasty has a well-established safety profile, and recent advancements in imaging techniques, cement composition, and procedural methodologies have significantly reduced the associated risks, making it a widely accepted therapeutic option in the orthopedic and neurosurgical communities.
What Are the Major Benefits and Challenges of Vertebroplasty?
The advantages of vertebroplasty are multifaceted, providing substantial clinical benefits to patients with vertebral compression fractures, yet the procedure is not without its challenges. One of its primary benefits is the rapid and significant reduction of pain, which often occurs within hours post-procedure, enabling patients to regain mobility and return to their daily routines much faster than traditional open surgical treatments. This accelerated recovery is particularly crucial for elderly patients with limited physical capacity and those who suffer from multiple comorbidities that complicate their treatment. Furthermore, by stabilizing the fractured vertebra, vertebroplasty prevents further collapse and deformation of the spine, reducing the risk of progressive kyphosis, commonly known as a "dowager’s hump." Despite these benefits, vertebroplasty has sparked considerable debate in the medical community, primarily due to concerns regarding cement leakage—a complication that occurs when the injected material extrudes from the vertebral body into adjacent structures, potentially causing nerve root compression, embolism, or spinal cord injury. To mitigate these risks, there have been advancements in cement formulations, including the use of higher viscosity cements and refined injection techniques that allow for better control during the procedure. Another significant challenge lies in the selection of appropriate candidates for vertebroplasty, as its efficacy varies depending on the underlying cause of the fracture. While it has shown excellent outcomes in treating osteoporotic fractures, its effectiveness in fractures caused by malignant lesions or high-impact trauma remains a subject of ongoing research, highlighting the need for precise patient evaluation and individualized treatment planning.
How Does Vertebroplasty Compare to Other Treatment Options?
Vertebroplasty stands out as a preferred treatment for certain types of vertebral compression fractures due to its unique benefits, but it is often compared to other procedures like kyphoplasty and spinal fusion, each of which has its own strengths and limitations. Kyphoplasty, a related procedure, involves the use of a balloon tamp to create a cavity within the vertebra before cement is injected, which helps to restore some of the lost vertebral height and correct spinal deformity. While kyphoplasty is more effective in reducing spinal curvature and preventing postural abnormalities, it is typically more expensive and time-consuming than vertebroplasty. Vertebroplasty, by contrast, involves direct cement injection, making it simpler, faster, and less costly. Spinal fusion, a more invasive surgical option, is usually reserved for severe cases involving multiple vertebrae or when there is significant spinal instability. This procedure involves placing bone grafts and metallic hardware to permanently join two or more vertebrae, which increases the complexity, recovery time, and the potential for complications. Due to its minimally invasive nature, vertebroplasty is performed under local anesthesia and often as an outpatient procedure, making it an ideal choice for elderly or medically fragile patients who cannot tolerate the prolonged anesthesia or hospitalization required for more invasive surgeries. Moreover, vertebroplasty’s success rate in alleviating pain and stabilizing the fracture is comparable to or even exceeds that of more invasive techniques, making it a highly favorable option, especially when quick pain relief and a return to normal function are primary treatment goals. However, the choice between these options depends on various factors such as the degree of vertebral collapse, overall bone health, and patient-specific preferences following a thorough discussion of the risks and benefits of each treatment modality.
What Are the Market Dynamics Shaping Vertebroplasty Growth?
The growth in the vertebroplasty market is driven by several factors, including the rising prevalence of osteoporosis and related vertebral fractures, advancements in procedural technology, and shifting patient preferences towards less invasive treatment options. The global aging population is a key driver of demand for vertebroplasty, as osteoporosis is particularly prevalent among older adults, especially postmenopausal women, leading to a surge in the number of patients requiring treatment for vertebral compression fractures. Furthermore, the introduction of innovative cement formulations, such as bioactive and radiopaque cements, has improved procedural safety and outcomes, making vertebroplasty a more attractive option for both patients and healthcare providers. Additionally, improvements in imaging techniques, including the adoption of high-definition fluoroscopy and real-time 3D imaging, have enhanced procedural precision, reducing the risk of complications and cement leakage. The growing preference for outpatient and ambulatory surgical settings has also contributed to the market expansion, as vertebroplasty can often be performed without the need for prolonged hospitalization, thereby reducing overall healthcare costs and increasing patient satisfaction. Consumer behavior trends indicate a rising demand for treatments that offer rapid recovery and minimal disruption to daily life, further fueling the adoption of vertebroplasty. Increased awareness among healthcare professionals and patients about the benefits of early intervention for spinal fractures has led to more proactive treatment strategies, expanding the potential patient base. Furthermore, the entry of new market players and strategic partnerships among key stakeholders are expected to boost competition, foster innovation, and drive down costs, making vertebroplasty more accessible. As a result, the vertebroplasty market is poised for robust growth in the coming years, supported by a combination of demographic trends, technological innovations, and evolving patient and provider preferences.
Select Competitors (Total 42 Featured) -
Alphatec Spine, Inc.
DePuy Synthes (Johnson & Johnson)
Globus Medical, Inc.
IZI Medial Products
Medtronic
Merit Medical Systems, Inc.
Rontis
SPINUS (BMK Global Medical Company)
Stryker Corporation
Zavation
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
Global Economic Update
Vertebroplasty - Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Growing Prevalence of Spinal Compression Fractures Accelerates Vertebroplasty Adoption
Rising Geriatric Population Spurs Demand for Vertebroplasty Procedures
Increased Awareness of Minimally Invasive Spine Treatments Expands Market Opportunities
Advancements in Imaging Technology Drive Adoption of Precision-Guided Vertebroplasty
Shift Towards Minimally Invasive Techniques Over Traditional Open Surgeries Fuels Market Growth
Increasing Focus on Outpatient Settings Expands Market Reach for Vertebroplasty Services
Innovations in Bioactive Bone Cements Generate New Product Demand
Growing Popularity of Personalized, Patient-Specific Solutions Propels Market Expansion
Heightened Need for Effective Pain Management in Oncology Patients Increases Vertebroplasty Utilization
Wider Physician Training Programs Enhance Market Penetration of Vertebroplasty Procedures
Patient Preference for Shorter Recovery Time and Minimally Invasive Options Drives Adoption
Surging Healthcare Investments in Emerging Markets Open New Growth Opportunities
High Costs and Risk of Procedure-Related Complications Present Market Challenges
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Vertebroplasty by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 2: World Historic Review for Vertebroplasty by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 3: World 16-Year Perspective for Vertebroplasty by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
TABLE 4: World Vertebroplasty Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
III. MARKET ANALYSIS
UNITED STATES
Vertebroplasty Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 5: USA Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 6: USA Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
CANADA
TABLE 7: Canada Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 8: Canada Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
JAPAN
Vertebroplasty Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 9: Japan Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 10: Japan Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
CHINA
Vertebroplasty Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 11: China Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 12: China Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
EUROPE
Vertebroplasty Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 13: Europe Recent Past, Current & Future Analysis for Vertebroplasty by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 14: Europe Historic Review for Vertebroplasty by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 15: Europe 16-Year Perspective for Vertebroplasty by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
FRANCE
Vertebroplasty Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 16: France Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 17: France Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
GERMANY
Vertebroplasty Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 18: Germany Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 19: Germany Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
ITALY
TABLE 20: Italy Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 21: Italy Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
UNITED KINGDOM
Vertebroplasty Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 22: UK Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 23: UK Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
SPAIN
TABLE 24: Spain Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 25: Spain Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
RUSSIA
TABLE 26: Russia Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 27: Russia Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
REST OF EUROPE
TABLE 28: Rest of Europe Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 29: Rest of Europe Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
ASIA-PACIFIC
Vertebroplasty Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 30: Asia-Pacific Recent Past, Current & Future Analysis for Vertebroplasty by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 31: Asia-Pacific Historic Review for Vertebroplasty by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 32: Asia-Pacific 16-Year Perspective for Vertebroplasty by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
AUSTRALIA
Vertebroplasty Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
TABLE 33: Australia Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 34: Australia Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
INDIA
Vertebroplasty Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
TABLE 35: India Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 36: India Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
SOUTH KOREA
TABLE 37: South Korea Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 38: South Korea Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
REST OF ASIA-PACIFIC
TABLE 39: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 40: Rest of Asia-Pacific Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
LATIN AMERICA
Vertebroplasty Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
TABLE 41: Latin America Recent Past, Current & Future Analysis for Vertebroplasty by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 42: Latin America Historic Review for Vertebroplasty by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 43: Latin America 16-Year Perspective for Vertebroplasty by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
ARGENTINA
TABLE 44: Argentina Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 45: Argentina Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
BRAZIL
TABLE 46: Brazil Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 47: Brazil Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
MEXICO
TABLE 48: Mexico Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 49: Mexico Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
REST OF LATIN AMERICA
TABLE 50: Rest of Latin America Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 51: Rest of Latin America Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
MIDDLE EAST
Vertebroplasty Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
TABLE 52: Middle East Recent Past, Current & Future Analysis for Vertebroplasty by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 53: Middle East Historic Review for Vertebroplasty by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 54: Middle East 16-Year Perspective for Vertebroplasty by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
IRAN
TABLE 55: Iran Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 56: Iran Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
ISRAEL
TABLE 57: Israel Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 58: Israel Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
SAUDI ARABIA
TABLE 59: Saudi Arabia Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 60: Saudi Arabia Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
UNITED ARAB EMIRATES
TABLE 61: UAE Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 62: UAE Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
REST OF MIDDLE EAST
TABLE 63: Rest of Middle East Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 64: Rest of Middle East Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
AFRICA
Vertebroplasty Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
TABLE 65: Africa Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 66: Africa Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR